Article
Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity.
Infection and immunity - 1 Jan 2004
Newcombe J, Eales-Reynolds L-J, Wootton L, Gorringe A R, Funnell S G P, Taylor S C, McFadden J J
Abstract excerpt
Successful vaccines against serogroup A and C meningococcal strains have been developed, but current serogroup B vaccines provide protection against only a limited range of strains. The ideal meningococcal vaccine would provide cross-reactive immunity against the variety of strains that may be encountered in any community, but it is unclear whether the meningococcus possesses immune targets that have the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
